Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Current management of melanoma.

Literature DB >> 327949

Current management of melanoma.

H F Seigler, B F Fetter.

Abstract

Entities: Disease

Mesh：

Substances：
Antineoplastic Agents

Year: 1977 PMID： 327949 PMCID： PMC1396200 DOI： 10.1097/00000658-197707000-00001

Source DB: PubMed Journal: Ann Surg ISSN： 0003-4932 Impact factor: 12.969

× No keyword cloud information.

31 in total

1. In vivo effects of lymphocytes sensitized in vitro against tumor cells.

Authors: A J Treves; I R Cohen; B Schechter; M Feldman
Journal: Ann N Y Acad Sci Date: 1976 Impact factor: 5.691

2. GIANT PIGMENTED NEVI, MELANOMA, AND LEPTOMENINGEAL MELANOCYTOSIS: A CLINICAL AND HISTOPATHOLOGICAL STUDY.

Authors: W B REED; S W BECKER; S W BECKER; W R NICKEL
Journal: Arch Dermatol Date: 1965-02

3. RATES OF GROWTH OF PULMONARY METASTASES AND HOST SURVIVAL.

Authors: J S SPRATT; T L SPRATT
Journal: Ann Surg Date: 1964-02 Impact factor: 12.969

4. Melanoblastoma.

Authors: V J McGOVERN
Journal: Med J Aust Date: 1952-02-02 Impact factor: 7.738

5. Shared antigens between Mycobacterium bovis (BCG) and neoplastic cells.

Authors: P Minden; J K McClatchy; M Wainberg; D W Weiss
Journal: J Natl Cancer Inst Date: 1974-11 Impact factor: 13.506

6. The incidence and distribution of pigmented naevi in Ugandan Africans.

Authors: M G Lewis; K Johnson
Journal: Br J Dermatol Date: 1968-06 Impact factor: 9.302

7. Melanomas of the extremities complicated by in-transit metastases.

Authors: J S Stehlin; J L Smith; B S Jing; D Sherrin
Journal: Surg Gynecol Obstet Date: 1966-01

8. Immunotherapy of cancer with antibody.

Authors: H S Shin; G R Pasternack; J S Economou; R J Johnson; M L Hayden
Journal: Science Date: 1976-10-15 Impact factor: 47.728

9. Enzymatic susceptibility and spontaneous release of human melanoma tumor-associated antigens.

Authors: G M Stuhlmiller; H F Seigler
Journal: J Natl Cancer Inst Date: 1977-02 Impact factor: 13.506

10. Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens.

Authors: H Shiku; T Takahashi; H F Oettgen
Journal: J Exp Med Date: 1976-10-01 Impact factor: 14.307

9 in total

Current management of melanoma.

1. In vivo effects of lymphocytes sensitized in vitro against tumor cells.

2. GIANT PIGMENTED NEVI, MELANOMA, AND LEPTOMENINGEAL MELANOCYTOSIS: A CLINICAL AND HISTOPATHOLOGICAL STUDY.

3. RATES OF GROWTH OF PULMONARY METASTASES AND HOST SURVIVAL.

4. Melanoblastoma.

5. Shared antigens between Mycobacterium bovis (BCG) and neoplastic cells.

6. The incidence and distribution of pigmented naevi in Ugandan Africans.

7. Melanomas of the extremities complicated by in-transit metastases.

8. Immunotherapy of cancer with antibody.

9. Enzymatic susceptibility and spontaneous release of human melanoma tumor-associated antigens.

10. Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens.

1. Cerebral aspergillosis in liver transplantation.

2. Cancer in pregnancy: maternal-fetal conflict.

Review 3. Combined modality therapy of malignant melanoma.

4. Correlation between anergy and a circulating immunosuppressive factor following major surgical trauma.

5. The extent of primary melanoma excision. A re-evaluation--how wide is wide?

6. Tomographic gallium-67 citrate scanning. Useful new surveillance for metastatic melanoma.

7. Immune response of chimpanzee to purified melanoma 250 kilodalton tumor-associated antigen.

8. [Axillary recurrence after lymph node excision in malignant melanoma].

9. Diagnosis, treatment and prognosis of early melanoma. The importance of depth of microinvasion.